Moreover, increases in ADAR1 activity through gene amplification enhance lung tumorigenesis [145], while loss of ADAR1 function allows tumor cells to overcome resistance to immunotherapy by removing the checkpoint that restrains the dsRNA-mediated immune response pathway [146]. Here, ADAR is linked to neoplasm.